Serine racemase suppresses chondrogenic differentiation in cartilage in a Sox9-dependent manner

Journal of Cellular Physiology

Volumn 215, Issue 2, 2008, Pages 320-328

  Takarada, Takeshi ^a   Hinoi, Eiichi ^a   Takahata, Yoshifumi ^a   Yoneda, Yukio ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCIAN BLUE; ALKALINE PHOSPHATASE; COLLAGEN TYPE 10; COLLAGEN TYPE 2; ENZYME; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; PHOSPHOGLYCERATE DEHYDROGENASE; SERINE RACEMASE; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; HIGH MOBILITY GROUP PROTEIN; ISOMERASE; SOX-9 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; IN SITU HYBRIDIZATION; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; STAINING; TIBIA; ANIMAL; CELL LINE; CELL STRAIN COS1; CERCOPITHECUS; CYTOLOGY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHYSIOLOGY; STEM CELL; UPREGULATION; WISTAR RAT;

RATTUS;

ANIMALS; ANIMALS, NEWBORN; CARTILAGE; CELL DIFFERENTIATION; CELL LINE; CERCOPITHECUS AETHIOPS; CHONDROCYTES; COS CELLS; HIGH MOBILITY GROUP PROTEINS; IN SITU HYBRIDIZATION; MICE; RACEMASES AND EPIMERASES; RATS; RATS, WISTAR; RNA, MESSENGER; STEM CELLS; TIBIA; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; UP-REGULATION;

EID: 40949138228     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21310     Document Type: Article

References (34)

1. Akiyama H, Lyons JP, Mori-Akiyama Y, Yang X, Zhang R, Zhang Z, Deng JM, Taketo MM, Nakamura T, Behringer RR, McCrea PD, de Crombrugghe B. 2004. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev 18:1072-1087.
2. Akiyama H, Kamitani T, Yang X, Kandyil R, Bridgewater LC, Fellous M, Mori-Akiyama Y, de Crombrugghe B. 2005. The transcription factor Sox9 is degraded by the ubiquitin-proteasome system and stabilized by a mutation in a ubiquitin-target site. Matrix Biol 23:499-505.
3. Bi W, Huang W, Whitworth DJ, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B. 2001. Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci USA 98:6698-6703.
4. Chen Z, Huang W, Srinivas SR, Jones CR, Ganapathy V, Prasad PD. 2004. Serine racemase and D-serine transport in human placenta and evidence for a transplacental gradient for D-serine in humans. J Soc Gynecol Investig 11:294-303.
5. Chenu C, Serre CM, Raynal C, Burt-Pichat B, Delmas PD. 1998. Glutamate receptors are expressed by bone cells and are involved in bone resorption. Bone 22:295-299.
6. Foster JW, Dominguez-Steglich MA, Guioli S, Kowk G, Weiler PA, Stevanovic M, Weissenbach J, Mansour S, Young ID, Goodfellow PN. 1994. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372:525-530.
7. Hashimoto A, Oka T, Nishikawa T. 1995. Anatomical distribution and postnatal changes in endogenous free D-aspartate and D-serine in rat brain and periphery. Eur J Neurosci 7:1657-1663.
8. 0,+ expressed in the colon. Biochem Biophys Res Commun 291:291-295.
9. Hinoi E, Fujimori S, Nakamura Y, Yoneda Y. 2001. Group III metabotropic glutamate receptors in cultured rat calvarial osteoblasts. Biochem Bipohys Res Commun 281:341-346.
10. Hinoi E, Fujimori S, Takemori A, Kurabayashi H, Nakamura Y, Yoneda Y. 2002. Demonstration of expression of mRNA for particular AMPA and kainate receptor subunits in immature and mature cultured rat calvarial osteoblasts. Brain Res 943:112-116.
11. Hinoi E, Fujimori S, Yoneda Y. 2003. Modulation of cellular differentiation by N-methyl-D-aspartate receptors in osteoblasts. FASEB J 17:1532-1534.
12. Hinoi E, Wang L, Takemori A, Yoneda Y. 2005. Functional expression of particular isoforms of excitatory amino acid transporters by rodent cartilage. Biochem Pharmacol 70:70-81.
13. Hinoi E, Takarada T, Uno K, Inoue M, Murafuji Y, Yoneda Y. 2007. Glutamate suppresses osteoclastogenesis through the cystine/glutamate antiporter. Am J Pathol 170:1277-1290.
14. Iemata M, Takarada T, Hinoi E, Taniura H, Yoneda Y. 2007. Suppression by glutamate of proliferative activity through glutathione depletion mediated by the cystine/glutamate antiporter in mesenchymal C3H10T1/2 stem cells. J Cell Physiol 213:721-729.
15. Johnson JW, Ascher P. 1987. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325:529-531.
16. Kronenberg HM. 2003. Developmental regulation of the growth plate. Nature 423:332-336.
17. Laketic-Ljubojevic I, Suva LJ, Maathuis FJ, Sanders D, Skerry TM. 1999. Functional characterization of N-methyl-D-aspartic acid-gated channels in bone cells. Bone 25:631-637.
18. Mothet JP, Parent AT, Wolosker H, Brady RO, Jr., Linden DJ, Ferris CD, Rogawski MA, Snyder SH. 2000. D-Serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 97:4926-4931.
19. Mustafa AK, Kumar M, Selvakumar B, Ho GP, Ehmsen JT, Barrow RK, Amzel LM, Snyder SH. 2007. Nitric oxide S-nitrosylates serine racemase, mediating feedback inhibition of D-serine formation. Proc Natl Acad Sci USA 104:2950-2955.
20. +-independent transporter for small neutral amino acids that transports D-serine with high affinity. Neurosci Lett 287:231-235.
21. Oliet SH, Mothet JP. 2006. Molecular determinants of D-serine- mediated gliotransmission: From release to function. Glia 54:726-737.
22. Peet NM, Grabowski PS, Laketic-Ljubojevic I, Skerry TM. 1999. The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation. FASEB J 13:2179-2185.
23. Salter DM, Wright MO, Millward-Sadler SJ. 2004. NMDA receptor expression and roles in human articular chondrocyte mechanotransduction. Biorheology 41:273-281.
24. Skerry TM, Genever PG. 2001. Glutamate signalling in non-neuronal tissues. Trends Pharmacol Sci 22:174-181.
25. Strisovsky K, Jiraskova J, Barinka C, Majer P, Rojas C, Slunsher BS, Konvalinska J. 2003. Mouse brain serine racemase catalyzes specific elimination of L-serine to pyruvate. FEBS Lett 53S:44-48.
26. Takarada T, Hinoi E, Balcar VJ, Taniura H, Yoneda Y. 2004. Possible expression of functional glutamate transporters in the rat testis. J Endocrinol 181:233-244.
27. Wagner T, Wirth J, Meyer J, Zabel B, Held M, Zimmer J, Pasantes J, Bricarelli FD, Keutel J, Hustert E, et al. 1994. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene S OX9. Cell 79:1111-1120.
28. Wang L, Hinoi E, Takemori A, Takarada T, Yoneda Y. 2005a. Abolition of chondral mineralization by group III metabotropic glutamate receptors expressed in rodent cartilage. Br J Pharmacol 146:732-743.
29. Wang L, Hinoi E, Takemori A, Yoneda Y. 2005b. Release of endogenous glutamate by AMPA receptors expressed in cultured rat costal chondrocytes. Biol Pharm Bull 28:990-993.
30. Wang L, Hinoi E, Takemori A, Nakamichi N, Yoneda Y. 2006. Glutamate inhibits chondral mineralization through apoptotic cell death mediated by retrograde operation of the cystine/glutamate antiporter. J Biol Chem 281:24553-24565.
31. Wolosker H, Blackshaw S, Snyder SH. 1999. Serine racemase: A glial enzyme synthesizing D-serine to regulate glutamate-N-methyl- D-aspartate neurotransmission. Proc Natl Acad Sci USA 96:13409-13414.
32. Xia M, Liu Y, Figueroa DJ, Chiu CS, Wei N, Lawlor AM, Lu P, Sur C, Koblan KS, Connolly TM. 2004. Characterization and localization of a human serine racemase. Brain Res Mol Brain Res 125:96-104.
33. 3H]glutamate binding sites in rat adrenal medulla. Brain Res 383:387-391.
34. 3H]Glutamate binding sites in the rat pituitary. Neurosci Res 3:430-435.